Capital Southwest Provides First Lien Term Loan to Wastewater Specialties
May 08, 2017 20:02 pm UTC| Business
DALLAS, May 08, 2017 -- Capital Southwest Corporation (“Capital Southwest”) (Nasdaq:CSWC), announced today that it invested $11 million in a first lien term loan to Wastewater Specialties (“Wastewater” or the...
CommerceHub Announces First Quarter 2017 Financial Results
May 08, 2017 20:02 pm UTC| Business
Revenue of $24.6 million increases 11%, GAAP EPS is $0.06, adjusted EPS is $0.09Revenue excluding customers acquired through the Mercent acquisition increases 17% ALBANY, N.Y., May 08, 2017 -- CommerceHub, Inc....
CommerceHub Announces First Quarter 2017 Financial Results
May 08, 2017 20:02 pm UTC| Business
Revenue of $24.6 million increases 11%, GAAP EPS is $0.06, adjusted EPS is $0.09Revenue excluding customers acquired through the Mercent acquisition increases 17% ALBANY, N.Y., May 08, 2017 -- CommerceHub, Inc....
Coherus BioSciences Reports First Quarter 2017 Corporate Highlights and Financial Results
May 08, 2017 20:02 pm UTC| Business
REDWOOD CITY, Calif., May 08, 2017 -- Coherus BioSciences, Inc. (NASDAQ:CHRS), today reviewed corporate events and reported financial results for the quarter ended March 31, 2017. Corporate Highlights for the First...
Coherus BioSciences Reports First Quarter 2017 Corporate Highlights and Financial Results
May 08, 2017 20:02 pm UTC| Business
REDWOOD CITY, Calif., May 08, 2017 -- Coherus BioSciences, Inc. (NASDAQ:CHRS), today reviewed corporate events and reported financial results for the quarter ended March 31, 2017. Corporate Highlights for the First...
Editas Medicine to Present at Investor Conferences in May
May 08, 2017 20:02 pm UTC| Business
CAMBRIDGE, Mass., May 08, 2017 -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that management will participate in two upcoming investor conferences in May. Details are as...
Editas Medicine to Present at Investor Conferences in May
May 08, 2017 20:02 pm UTC| Business
CAMBRIDGE, Mass., May 08, 2017 -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that management will participate in two upcoming investor conferences in May. Details are as...